https://www.amgen.es/ 2024-09-11 daily 0.5 https://www.amgen.es/prensa 2025-12-26 daily 0.5 https://www.amgen.es/sobre-amgen 2024-09-18 daily 0.5 https://www.amgen.es/ciencia-e-innovacion 2024-09-19 daily 0.5 https://www.amgen.es/responsabilidad 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas 2024-09-19 daily 0.5 https://www.amgen.es/informacion-de-cookies 2024-09-12 daily 0.5 https://www.amgen.es/trabajar-en-amgen 2024-09-08 daily 0.5 https://www.amgen.es/privacidad 2024-10-04 daily 0.5 https://www.amgen.es/politica-de-privacidad-para-profesionales-sanitarios 2024-09-12 daily 0.5 https://www.amgen.es/efpia 2024-09-08 daily 0.5 https://www.amgen.es/search-results 2024-09-02 daily 0.5 https://www.amgen.es/social-media-policy 2024-09-03 daily 0.5 https://www.amgen.es/terminos-de-uso 2024-10-18 daily 0.5 https://www.amgen.es/media 2025-12-15 monthly 0.5 https://www.amgen.es/historias 2026-03-13 always https://www.amgen.es/sitemap 2024-05-30 monthly 0.5 https://www.amgen.es/page-error 2024-09-03 daily 0.5 https://www.amgen.es/page-not-found 2024-09-12 daily 0.5 https://www.amgen.es/prensa/premios-genetica 2026-02-24 daily 0.5 https://www.amgen.es/sobre-amgen/mision-y-valores 2024-09-13 daily 0.5 https://www.amgen.es/sobre-amgen/nuestros-farmacos 2025-09-11 daily 0.5 https://www.amgen.es/sobre-amgen/nuestra-historia 2024-09-13 daily 0.5 https://www.amgen.es/sobre-amgen/transparencia 2025-06-25 daily 0.5 https://www.amgen.es/sobre-amgen/contacto 2024-09-13 daily 0.5 https://www.amgen.es/sobre-amgen/nuestro-equipo-directivo 2024-09-13 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/produccion 2024-09-13 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/biotecnologia 2024-09-13 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/ensayos-clinicos 2024-09-13 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/modalidades-terapeuticas 2024-09-13 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/biosimilares 2024-09-19 daily 0.5 https://www.amgen.es/responsabilidad/fundacion-amgen 2026-03-13 daily 0.5 https://www.amgen.es/responsabilidad/la-responsabilidad-corporativa-en-espana 2025-10-13 daily 0.5 https://www.amgen.es/responsabilidad/responsabilidad-corporativa 2026-01-16 daily 0.5 https://www.amgen.es/responsabilidad/etica-empresarial-y-compliance 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/cardiologia 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/inflamacion 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/nefrologia 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/oncologia 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/metabolismo-oseo 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas/hematologia 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas/farmacovigilancia 2024-09-18 daily 0.5 https://www.amgen.es/media/press-releases 2024-09-20 monthly 0.5 https://www.amgen.es/sobre-amgen/transparencia/transferencias-de-valor-realizadas-en-2022 2025-06-13 daily 0.5 https://www.amgen.es/sobre-amgen/transparencia/transferencias-de-valor-realizadas-en-2023 2025-06-13 daily 0.5 https://www.amgen.es/sobre-amgen/transparencia/transferencias-de-valor-realizadas-en-2024 2025-06-27 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/produccion/como-se-producen-los-farmacos-biotecnologicos 2024-09-13 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/biotecnologia/como-se-descubren-y-desarrollan-los-farmacos-biotecnologicos 2024-09-19 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/biotecnologia/la-ciencia-de-la-biotecnologia 2024-09-19 daily 0.5 https://www.amgen.es/ciencia-e-innovacion/biotecnologia/como-podria-ser-el-futuro-de-los-farmacos-biotecnologicos 2024-09-19 daily 0.5 https://www.amgen.es/areas-terapeuticas/cardiologia/hipercolesterolemia 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/inflamacion/psoriasis 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/inflamacion/artritis-psoriasica 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/inflamacion/artritis-reumatoide 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/inflamacion/enfermedad-de-crohn 2024-09-13 daily 0.5 https://www.amgen.es/areas-terapeuticas/nefrologia/hiperparatiroidismo-secundario 2024-11-22 daily 0.5 https://www.amgen.es/areas-terapeuticas/oncologia/cancer-de-pulmon 2025-10-30 daily 0.5 https://www.amgen.es/areas-terapeuticas/oncologia/mieloma-multiple 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas/oncologia/cancer-de-mama 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas/oncologia/cancer-de-colon 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas/metabolismo-oseo/osteoporosis 2024-09-18 daily 0.5 https://www.amgen.es/areas-terapeuticas/hematologia/trombocitopenia-inmune-primaria 2024-09-18 daily 0.5 https://www.amgen.es/historias/categories/patients 2024-09-03 monthly 1.0 https://www.amgen.es/historias/categories/noticias-corporativas 2024-09-03 monthly 1.0 https://www.amgen.es/historias/categories/ciencia 2024-09-03 monthly 1.0 https://www.amgen.es/historias/categories/responsabilidad 2024-09-03 monthly 1.0 https://www.amgen.es/historias/categories/nuestra-cultura 2024-09-03 monthly 1.0 https://www.amgen.es/historias/2021/02/amgen-liderando-una-nueva-era-de-innovacion-biotecnologica 2024-05-30 daily 0.5 https://www.amgen.es/historias/2021/02/aplicando-el-conocimiento-del-genoma-humano-en-amgen 2024-05-30 daily 0.5 https://www.amgen.es/historias/2021/04/10-cosas-que-debes-saber-sobre-los-anticuerpos 2024-09-02 daily 0.5 https://www.amgen.es/historias/2021/04/amgen-una-de-las-mejores-companias-para-trabajar-en-espana 2024-05-30 daily 0.5 https://www.amgen.es/historias/2021/04/nueva-plataforma-digital-educativa-cuidatusalud 2024-05-30 daily 0.5 https://www.amgen.es/historias/2021/05/nace-prevenim-la-primeraaplicacion-que-guia-a-los-pacientes-tras-sufrir-un-infarto 2024-05-30 daily 0.5 https://www.amgen.es/historias/2021/10/estrenamos-nuevo-modelo-de-trabajo 2024-05-30 daily 0.5 https://www.amgen.es/historias/2021/12/amacadalatido-la-campana-que-promueve-habitos-cardiosaludables 2024-08-02 daily 0.5 https://www.amgen.es/historias/2022/02/amgen-homenajea-a-mujeres-pioneras-en-ciencias-de-la-salud 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/02/amgen-se-suma-al-barcelona-health-hub 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/03/amgen-reconocida-por-su-responsabilidad-ambiental-y-social 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/03/fundacion-amgen-dona-medio-millon-dolares-pueblo-ucraniano 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/04/nace-la-plataforma-para-la-prevencion-de-la-fractura-por-osteoporosis 2024-09-02 daily 0.5 https://www.amgen.es/historias/2022/04/oculta-intriga-a-flor-de-piel 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/06/amgen-se-suma-al-programa-de-empresas-y-diversidad 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/07/amgen-premiada-por-fomentar-el-talento-femenino 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/09/genera-un-podcast-sobre-divulgacion-cientifica-que-vera-la-luz-en-otono 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/09/mieloma-multiple 2024-05-30 daily 0.5 https://www.amgen.es/historias/2022/11/llega-genera 2024-05-29 daily 0.5 https://www.amgen.es/historias/2023/01/amgen-empresa-top-employer-2023 2024-05-30 daily 0.5 https://www.amgen.es/historias/2023/01/el-bueno-el-feo-el-malo 2024-09-02 daily 0.5 https://www.amgen.es/historias/2023/02/ampliamos-mural-pioneres 2024-05-30 daily 0.5 https://www.amgen.es/historias/2023/03/estrenamos-nuevas-oficinas 2024-05-30 daily 0.5 https://www.amgen.es/historias/2023/04/amgen-transferciencia-llega-galicia 2024-05-30 daily 0.5 https://www.amgen.es/historias/2023/04/amgen-reconocida-mejores-empresas-trabajar 2024-05-30 daily 0.5 https://www.amgen.es/historias/2023/09/encuesta-cardiologia-2023 2024-11-11 daily 0.5 https://www.amgen.es/historias/2023/09/amgen-partners-of-choice 2024-11-11 daily 0.5 https://www.amgen.es/historias/2023/09/la-oncologia-de-precision-puede-ayudar-a-mas-de-un-70-por-ciento-de-pacientes-de-cancer 2024-11-11 daily 0.5 https://www.amgen.es/historias/2023/10/cardioplan-recibe-el-premio-del-ministerio-de-sanidad-a-la-excelencia-en-el-marco-de-la-estrategia-de-salud-cardiovascular 2024-10-08 daily 0.5 https://www.amgen.es/historias/2023/11/la-genetica-omnipresente-en-la-medicina-del-futuro 2024-10-22 daily 0.5 https://www.amgen.es/historias/2023/11/mucho-mas-que-una-palabra-un-cortometraje-sobre-la-importancia-de-los-avances-en-genetica 2024-11-20 daily 0.5 https://www.amgen.es/historias/2024/01/amgen-es-reconocida-con-el-distintivo-igualdad-en-la-empresa 2024-11-20 daily 0.5 https://www.amgen.es/historias/2024/03/nuestro-programa-de-telerehabilitacion-cardioplan-ya-beneficia-a-mas-de-1100-pacientes 2024-10-08 daily 0.5 https://www.amgen.es/historias/2024/05/cardioplan-recibe-el-premio-del-ministerio-de-sanidad-a-la-excelencia-en-el-marco-de-la-estrategia-de-salud-cardiovascular 2024-11-20 daily 0.5 https://www.amgen.es/en/historias/2024/05/cardioplan-recibe-el-premio-del-ministerio-de-sanidad-a-la-excelencia-en-el-marco-de-la-estrategia-de-salud-cardiovascular 2024-10-22 daily 0.5 https://www.amgen.es/historias/2024/05/el-conseller-de-salut-de-la-generalitat-de-catalunya-visita-las-nuevas-oficinas-de-amgen-en-barcelona 2024-10-22 daily 0.5 https://www.amgen.es/historias/2024/09/magia-y-medicina-para-concienciar-sobre-prevencion-secundaria-cardiovascular 2024-09-26 daily 0.5 https://www.amgen.es/historias/2024/10/historias-destacadas 2024-11-05 daily 1.0 https://www.amgen.es/historias/2025/03/el-cribado-de-cancer-colorrectal-podria-salvar-3600-vidas-en-espana 2025-04-09 daily 0.5 https://www.amgen.es/historias/2025/05/enfermedad-ocular-tiroidea 2025-05-23 daily 0.5 https://www.amgen.es/historias/2025/07/revolucionamos-el-diseno-de-medicamentos-con-nuestra-biblioteca-codificada-por-adn 2025-07-15 daily 0.5 https://www.amgen.es/historias/2025/07/una-encuesta-revela-que-los-pacientes-con-enfermedad-psoriasica-no-reciben-la-atencion-adecuada-en-cuanto-a-su-vida-sexual 2025-07-15 daily 0.5 https://www.amgen.es/historias/2025/09/descifrando-enfermedades-como-nuestro-enfoque-omico-impulsa-tratamientos-mas-precisos 2025-09-16 daily 0.5 https://www.amgen.es/historias/2025/11/lanzamos-los-primeros-premios-de-periodismo-y-divulgacion-sobre-genetica 2026-01-23 daily 0.5 https://www.amgen.es/historias/2025/12/el-programa-educativo-amgen-transferciencia-aterriza-en-andalucia 2025-12-09 daily 0.5 https://www.amgen.es/historias/2026/03/transformamos-el-clasico-de-caperucita-para-promover-la-salud-cardiovascular 2026-03-12 daily 0.5 https://www.amgen.es/cs-cz/historias/2026/03/transformamos-el-clasico-de-caperucita-para-promover-la-salud-cardiovascular 2024-10-22 daily 0.5 https://www.amgen.es/nl-nl/historias/2026/03/transformamos-el-clasico-de-caperucita-para-promover-la-salud-cardiovascular 2023-04-21 daily 0.5 https://www.amgen.es/media/press-releases/2026/03/una-caperucita-del-siglo-xxi-para-promover-la-salud-cardiovasclar 2026-03-16 daily 0.5 https://www.amgen.es/media/press-releases/2025/01/la-ce-aprueba-una-nueva-indicacion-de-blinatumomab-para-pacientes-adultos-con-leucemia-linfoblastica-aguda 2025-03-18 daily 0.5 https://www.amgen.es/media/press-releases/2025/03/un-tratamiento-de-amgen-mejora-significativamente-los-sintomas-de-la-miastenia-gravis-generalizada-una-enfermedad-rara-y-autoinmune 2025-03-25 daily 0.5 https://www.amgen.es/media/press-releases/2025/04/el-cribado-de-cancer-colorrectal-podria-salvar-vidas-en-espana 2025-04-08 daily 0.5 https://www.amgen.es/media/press-releases/2024/01/amgen-distintivo-igualdad-en-la-empresa 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2024/03/mas-de-1100-pacientes-se-benefician-programa-cardioplan 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2024/06/resultados-positivos-estudio-fase-3-mitigate 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2024/09/nuevos-datos-en-leucemia-linfoblastica-aguda-en-pacientes-pediatricos 2024-12-18 daily 0.5 https://www.amgen.es/en/media/press-releases/2024/09/nuevos-datos-en-leucemia-linfoblastica-aguda-en-pacientes-pediatricos 2022-01-15 daily 0.5 https://www.amgen.es/media/press-releases/2024/10/tratamiento-de-la-miastenia-gravis-generalizada 2024-11-14 daily 0.5 https://www.amgen.es/media/press-releases/2023/01/amgen-empresa-top-employer-2022 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/01/el-bueno-el-feo-el-malo 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/02/ampliamos-mural-pioneres 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/03/estrenamos-nuevas-oficinas 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/04/amgen-reconocida-mejores-empresas-trabajar 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/04/amgen-transferciencia-llega-galicia 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/06/nuevos-datos-codebreak-200 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/09/amgen-partners-of-choice 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/09/amgen-presenta-nuevos-datos 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/09/encuesta-cardiologia-2023 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/10/adquisicion-horizon-therapeutics-plc 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/10/amgen-completa-adquisicion-horizon-therapeutics 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2023/11/amgen-lanza-cortometraje-de-ficcion 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/01/amgen-empresa-top-employer-2022 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/01/la-comision-europea-aprueba-sotorasib 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/02/amgen-homenajea-a-mujeres-pioneras-en-ciencias-de-la-salud 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/02/amgen-se-suma-al-barcelona-health-hub 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/03/amgen-homenajea-a-mujeres-pioneras-en-ciencias-de-la-salud 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/03/fundacion-amgen-dona-medio-millon-dolares-pueblo-ucraniano 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/04/nace-la-plataforma-para-la-prevencion-de-la-fractura-por-osteoporosis 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/04/oculta-intriga-a-flor-de-piel 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/06/amgen-se-suma-al-programa-de-empresas-y-diversidad 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/07/amgen-premiada-por-fomentar-el-talento-femenino 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/09/esmo-2022 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/09/esmo-2022-sotorasib 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/09/genera-podcast 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2022/09/mieloma-multiple 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/01/inhibidor-gen-kras-g12c-respuesta-duradera-pacientes-cancer-pulmon-celulas-no-pequenas-avanzado 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/01/miquel-balcells-nuevo-director-amgen-iberia 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/02/amgen-liderando-nueva-era-de-innovacion-biotecnologica 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/02/aplicando-el-conocimiento-del-genoma-humano-en-amgen 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/02/cuida-tu-salud-2021 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/02/nace-red-amgen-nueva-plataforma-digital-contenidos-personalizados-profesionales-sanitarios 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/02/sotorasib-reduce-60-por-ciento-tamano-tumoral-cancer-pulmon-celulas-no-pequenas 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/03/amgen-anuncia-la-adquisicion-de-five-prime-therapeutics 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/03/amgen-presenta-nuevos-datos-de-supervivencia-pacientes-pediatricos-leucemia-linfoblastica-aguda 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/03/programa-educativo-amgen-transferciencia 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/04/10-cosas-que-debes-saber-sobre-los-anticuerpos 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/04/amgen-una-de-las-mejores-companias-para-trabajar-en-espana 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/04/nueva-plataforma-digital-educativa-cuidatusalud 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/05/nace-prevenim 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/06/amgen-presenta-nuevos-datos-mejora-supervivencia-global-cancer-gastrico-o-de-union-gastroesofagica 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/06/amgen-presenta-nuevos-datos-supervivencia-global-en-cancer-pulmon-celulas-no-pequenas 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/07/amgen-adquiere-la-empresa-privada-teneobio 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/07/amgen-y-la-federacion-internacional-de-asociaciones-de-psoriasis-lanzan-un-reto-mundial 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/07/lanzamos-un-reto-mundial-para-mejorar-el-tratamiento-de-la-enfermedad-psoriasica 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/08/evolocumab-mejora-estabilidad-placas-pacientes-sindrome-coronario-agudo 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/09/amgen-presenta-datos-prometedores-para-el-tratamiento-del-cancer-colorrectal 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/09/amgen-presenta-nuevos-avances-en-oncologia-toracica 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/09/la-oncologia-de-precision-puede-ayudar-a-mas-de-un-70-por-ciento-de-pacientes-de-cancer 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/10/estrenamos-nuevo-modelo-de-trabajo 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2021/12/amacadalatido-la-campana-que-promueve-habitos-cardiosaludables 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/02/amgen-participa-en-una-jornada-sobre-liderazgo-y-talento-femenino 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/02/inaugurada-jornada-post-midyear-novedades-farmacia-hospitalaria 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/03/carta-a-los-pacientes-covid19 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/03/carta-profesional-sanitario-covid-19 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/03/medidas-tomadas-amgen-covid-19 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/04/43-por-ciento-islandeses-positivos-covid-19-son-asintomaticos 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/04/amgen-y-adaptative-biotechnologies-se-unen-para-desarrollar-un-tratamiento-para-el-coronavirus 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/04/medidas-amgen-contra-el-coronavirus 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/04/testeo-masivo-fundamental-para-detener-propagacion-covid 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/06/amgen-desarrolla-mi-yo-ahora-mindfulness-contra-covid-19 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/06/amgen-lanza-mi-yo-ahora-aplicacion-mindfulness-para-la-gestion-emocional-del-covid19 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/06/amgen-presenta-nuevos-datos-clinicos-amg-510-tumores-solidos-congreso-virtual-asco-2020 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/09/amgen-presenta-nuevos-datos-clinicos-tratamiento-cancer-pulmon-esmo-2020 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/09/evolocumab-en-combinacion-reduce-38-porciento-colesterol-ldl-hipercolesterolemia-familiar 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/09/mayor-inversion-abordaje-mieloma-multiple-cuadruplicaria-beneficio-social 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/10/206razones-para-cuidar-de-la-salud-de-nuestros-huesos 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2020/10/el-impacto-invisible-de-la-psoriasis-y-la-artritis-psoriasica-en-los-pacientes 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/02/la-comision-europea-aprueba-blincyto 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/03/empleo-femenino-amgen-superior-media-industria-farmaceutica 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/03/hospital-santa-creu-sant-pau-se-une-a-medplan 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/03/primer-programa-inteligencia-artificial-hospital-la-princesa 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/03/salud-renal-y-corazon 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/04/declaracion-sobre-la-osteoporosis-y-su-tratamiento 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/04/grupo-oat-reconoce-compromiso-amgen-mejora-adherencia-tratamiento 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/amgen-es-estrena-canal-en-youtube 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/amgen-lanza-mimomento-primera-app-mindfulness-mieloma-multiple 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/amgen-presenta-asco-2019-primeros-datos-clinicos-amg-510-inhibidor-krasg12c 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/amgen-presenta-datos-supervivencia-global-blincyto-blinatumomab-congreso-eha-2019 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/amgen-presenta-resultados-amg-420-mieloma-multiple-refractario-recaida 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/mas-de-30-hospitales-se-unen-para-concienciar-sobre-el-colesterol-elevado 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/06/primera-aplicacion-midfulness-pacientes-mieloma-multiple 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/07/biotecnometro-2019-biotecnologia 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/07/siete-de-cada-diez-nulo-bajo-conocimiento-biotecnologia 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/09/cuarenta-por-ciento-supervivientes-infarto-miocardio-no-cree-su-enfermedad-cronica 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/09/cuatro-de-cada-diez-supervivientes-de-infarto-de-miocardio-no-considera-cronica-su-enfermedad 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/09/estudio-candor-mieloma-multiple-kyprolis-daratumumab-supervivencia-libre-progresion 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/09/nuevas-guias-europeas-colesterol-recomiendan-niveles-ldl-mas-bajos 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/10/amgen-participa-primer-foro-esp-mujeres-sanidad 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/10/amgen-presenta-datos-clinicos-nuevo-inhibidor-gen-krasg12c-esmo-2019 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/10/corto-osteoporosis-manana-siempre 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/11/aqaward-fina-llados-best-manager 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/11/protect-ur-life-campana-europea 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/11/protect-ur-life-malaga-2019 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/11/salvar-a-hope-escape-room-2019 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2019/11/transferciencia-2019 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/01/comision_europea_aprueba-mvasi_tratamiento_cancer 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/02/dia-mundial-cancer 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/02/opinion-favorable-chmp-kyprolis 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/03/dia-europeo-prevencion-riesgo-cardiovascular 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/03/opinion-positiva-chp-abp980 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/03/paciente-mieloma-multiple 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/03/repatha-previene-infarto-ictus 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/04/lo-que-debe-saber-cancer-colon 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/05/nueva-indicacion-kyprolis-carfilzomib-mieloma-multiple-recaida 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/05/programas-cribado-cancer-colorrectal-salvan-vidas 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/05/repatha_evolocumab_aprobado_europa_prevencion_infartos 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/09/amgen-lanza-primer-biosimilar 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/10/amgen-lanza-en-esp-angevita-tratamiento-enfermedades-inflamatorias 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/10/hospitalet-llobregat-ofrece-mediciones-colesterol-densitometria-gratuitas 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/11/escape-room-universidad-complutense-madrid-medicina-personalizada 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2018/12/30-por-ciento-de-las-mujeres-considera-la-osteoporosis-un-riesgo 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/01/v216-nuevos_estudios_muestran_que_parsabiv_etelcalcetida_reduce_significativamente_las 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/03/v217-blincyto_blinatumomab_mejora_significativamente_la_supervivencia_global 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/03/v218-un_ensayo_de_fase_iii_demuestra_que_kyprolis_carfilzomib_mejora_significativamente 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/03/v219-la_reduccion_de_los_niveles_de_c-ldl_con_repatha_evolocumab_no_tuvo_un_efecto 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/03/v220-la_comision_europea_autoriza_amgevita_biosimilar_de_adalimumab_para_el_tratamiento 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/03/v221-repatha_reduce_en_un_20_por_ciento_los_eventos_cardiovasculares_mayores_en_pacientes 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/04/v222-amgen_entre_las_50_mejores_empresas_para_trabajar_en_espana 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/07/kyprolis-aspire 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/08/amgen-esc-analisis-niveles-ldl 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/09/amgen-easd 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/09/biosimilar-abp-980 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/09/islandia-en-360 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/10/parsabiv 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/10/solo-entre-el-20-y-el-33-por-ciento-de-los-pacientes 2024-09-20 daily 0.5 https://www.amgen.es/media/press-releases/2017/12/kyprolis_prolonga_supervivencia_global_mieloma_aspire 2024-09-20 daily 0.5